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Along with inadequate access to high-quality care, competing health priorities, fragile
health systems, and conflicts, there is an associated delay in evidence generation and
research from LMICs. Lack of basic epidemiologic understanding of the disease burden
in these regions poses a significant knowledge gap as solutions can only be developed
and sustained if the scope of the problem is accurately defined. Congenital heart disease
(CHD), for example, is the most common birth defect in children. The prevalence of
CHD from 1990 to 2017 has progressively increased by 18.7% and more than 90% of
children with CHD are born in Low and Middle-Income Countries (LMICs). If diagnosed
and managed in a timely manner, as in high-income countries (HICs), most children lead
a healthy life and achieve adulthood. However, children with CHD in LMICs have limited
care available with subsequent impact on survival. The large disparity in global health
research focus on this complex disease makes it a solid paradigm to shape the debate.
Despite many challenges, an essential aspect of improving research in LMICs is the
realization and ownership of the problem around paucity of local evidence by patients,
health care providers, academic centers, and governments in these countries. We have
created a theory of change model to address these challenges at a micro- (individual
patient or physician or institutions delivering health care) and a macro- (government and
health ministries) level, presenting suggested solutions for these complex problems. All
stakeholders in the society, from government bodies, health ministries, and systems, to
frontline healthcare workers and patients, need to be invested in addressing the local
health problems and significantly increase data to define and improve the gaps in care
in LMICs. Moreover, interventions can be designed for a more collaborative and effective
HIC-LMIC and LMIC-LMIC partnership to increase resources, capacity building, and
representation for long-term productivity.
Keywords: complex care, contextual clinical research, global health, global health inequity, research disparity,
theory of change
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INTRODUCTION

A meta-analysis conducted in 2019 reported an RHD prevalence
of 8.2–31.0 per 1,000 in low income countries and 5.5–13.5 per
1,000 in LMICs (13). In 2015, just five countries (India, China,
Pakistan, Indonesia, and the Democratic Republic of the Congo)
accounted for 73% of the global cases of RHD. Like CHD, patients
with RHD also present with significantly advanced disease. Most
RHD patients usually present with moderate-to-severe valvular
heart disease associated with pulmonary hypertension and up to
a quarter of patients present with left ventricular dysfunction,
reflecting delayed referral patterns to tertiary care centers (14).
Due to the unique disease spectrum of patients with heart
disease in LMICs, management needs to be tailored and demands
a thoughtful and cautious approach. Late presenting left to
right CHD shunt lesions are rarely seen in HICs, while it is a
common occurrence in LMICs. Data around the management
of such patients is scarce and leads to variation in practices
(15–17). Cyanosis, coagulopathies, diastolic dysfunction, and
hyper-viscosity increase post-operative morbidity and mortality
in cyanotic heart lesions like the tetralogy of Fallot (7). Similarly,
management of critical CHD conditions like transposition of
great vessels is remarkably different in LMICs i.e., 2/3rd of
patients, in a large global registry of CHD patients from LMICs,
presented late and underwent a primary arterial switch operation
beyond 4 weeks of age while 20% cases had a two-staged arterial
switch (18).

Why Do We Need Contextually Relevant
Data From LMICs?
Low- and middle-income countries (LMICs) encompass 92%
of the global disease burden (1), and yet are severely lacking
in resources to manage complex care. The disparity of disease
burden to resources available is daunting, i.e., HIC has over
100 times more cardiac surgeons than LMIC, and while there
are more than 4,000 cardiac centers worldwide, only one center
per 10 million population exists in LMIC (2). Despite these
differences, there is a lack of basic epidemiologic understanding
of the disease burden in these regions. A large knowledge
gap is a hindrance toward identifying appropriate solutions to
multifaceted healthcare challenges. This stark contrast in disease
burden vs. research disparity has important implications toward
complex diseases as they remain low on healthcare improvement
agendas (3). We use the example of pediatric heart disease to
highlight this disparity, the challenges associated with contextual
evidence generation and propose some solutions to overcome
these barriers.
Congenital heart disease (CHD) is the most common birth
defect in children. The prevalence of CHD from 1990 to 2017
has progressively increased by 18.7% (4), and more than 90%
of children with CHD are born in LMICs (5). The spectrum of
CHD ranges from simple defects managed through conservative
observation vs. complex conditions requiring surgical or catheter
based intervention for survival. If managed in a timely manner,
as in high-income countries (HICs), the majority of children
lead a healthy life (5). However, children with CHD in LMICs
have limited care available (6). According to Global burden of
Disease (GBD) 2017, there are 261,247 deaths due to CHD
annually with more than 21 million years of life (YLL) and a
similarly high number of disability-adjusted life years (DALYs)
lost (4). Since 1990 CHD mortality for infants has declined by
only 6% in the low sociodemographic index (SDI) subgroup
compared with a decline of more than 50% in the middle
to high SDI subgroups (4). Additional to the disease burden,
patients in LMICs have a distinct disease spectrum, often present
late and with serious comorbidities (e.g., malnutrition, blood
stream and lung infections) or complications (7). Inadequate
quality of health care, poor infrastructure, cost of care, dearth
of equipment, expertise and skills, are some of the problems
unique to LMICs adding to the complexity of managing these
patients (8). Due to these factors there is significantly higher preoperative and operative mortality among these patients in LMICs
when compared with HICs (9). These patients also have more
pre- and post-operative morbidities significantly affecting their
outcomes. More than half of pre-operative patients with CHD in
LMICs had severe malnutrition (10). Compared to HIC, major
infections contributed toward increased post-operative mortality
and morbidity (increased ventilation time and ICU stays) in
LMICs (11).
The scenario is not much different for acquired heart diseases.
There has been a marked decline in the prevalence of rheumatic
heart disease (RHD) in developed countries (12). However, in
LMICs, RHD continues to pose a significant public health issue.
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How Much Is the Data Deficit?
Lack of contextually applicable guidelines leads to the use of
HIC guidelines which can be impractical or even impossible and
may lead to heterogeneity in care pathways and variability in
outcomes (19, 20). LMICs account for 90% of the world’s CHD
population, yet there is an extreme dearth of data and health care
research originating from these countries. The Global Burden of
Disease 2017 study on CHD reports little to no direct data on
CHD outcomes from a majority of the LMICs (4).

BARRIERS TO EVIDENCE GENERATION IN
LMICS
Despite realization of the importance of contextual research
and evidence generation for local, cost-effective solutions in the
LMIC, progress has been sluggish and uncoordinated. Therefore,
it is imperative to recognize the barriers to conducting research
and availability of data in LMICs so that systemic solutions can be
designed to address them. These barriers can be broadly classified
as following:

Competing Public Health Priorities Leading
to Inadequate Funding and Resources for
Complex Care CHD Research
External funding comprising international donors, grants, and
research collaborators encompass 90% of the resources for
research in LMICs (21). However, the primary agenda for
the largest funding health agencies in LMICs like the USAID,
UKAID, Welcome Trust, WHO, UNICEF, Bill and Melinda Gates
Foundation, and The Global Fund, continues to be infectious
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proper equipment, organized national databases and skilled
human resources (analysts, masters level, and Ph.D.- level
graduates, statisticians, data scientists, etc.) (28). A lack of vision
and incentivization to generate local evidence also transcribes
into limited mentorship of young physicians and emerging
health leaders in the importance of local data and contextual
research. Additionally, weak governance and accountability
around mentorship lead to inconsistent and ineffective coaching
of the early career physicians. Few health care providers with
limited research skills enter the workforce not adding much to
the national capacity to do high quality research or evidence
generation (24).

diseases, vaccines, and nutritional disorders. These diseases
remain the focus in global health like Sustainable Development
Goals indicators, driven mainly by donor interest. From 1990 to
2015, in LMICs, infant mortality rates dropped by more than
50% for infectious diseases and protein malnutrition while the
death rate from CHD persisted, springing it up to the 5th leading
cause of death (3). Despite this changing landscape of disease
spectrum, minimum funds are allocated for evidence generation
and research around CHD in LMICs. Policy Cures Research, a
global health body for research and data collection and analysis,
reported that 70% of the total neglected disease investment
focused on HIV/AIDS, tuberculosis, and malaria in 2018, while
CHD did not fall in their neglected diseases panel, and acute
rheumatic fever received only 0.1% of this funding (22). Deepseated disparities in the process of fund allocation are further
highlighted by a survey conducted in 2010 where 85% of grant
reviewers felt inadequately trained in grant review (23).

Poor Representation in Global Health
Forums
Poor representation of researchers from LMICs (29), a hierarchal
relation between HIC and LMIC research collaborators (30) and
a significant publication bias (31) against data from LMIC points
toward a disparity between the research/researchers from the
HICs vs. those in LMICs especially within the arena of global
health (32). Such a disparity is yet another reason for lack of
evidence from LMICs.

Lack of a Culture That Values and
Supports Research
Many academic medical centers or health care delivery institutes
in LMICs fail to adequately recognize their role in developing
a clear vision around contextual evidence generation and
research to identify more cost-effective measures of health
care delivery. Frequently health care “leaders” in LMICs are
unable to understand that contextual data and research is
probably the most effective way of improving the health care
outcomes in their countries (19). Apart from a few large
tertiary care centers in LMICs, most local organizations do not
invest in or support research conferences, workshops, or reward
research productivity as a part of their academic objectives (24).
Centers also provide more financial incentives for extra clinical
productivity rather than for research work, thus making research
work a lesser priority. Moreover, LMICs have a lower patient to
physician ratios resulting in competing clinical demands, thus
leaving inadequate time for quality research for the inundated
physicians working in academic settings. For example, CHD
prevalence in Pakistan is comparable to the United States, yet
compared to the US there are < 5% pediatric cardiac care
centers and < 1% of the pediatric cardiologists present in the
country to manage overwhelming burden of disease (17, 25).
Similar trends are seen in many other LMICs i.e., 0.04 adult
cardiac surgeons and 0.03 pediatric cardiac surgeons per million
population, compared with 7.15 adult cardiac surgeons and 1.67
pediatric cardiac surgeons in high-income countries (26). There
is a lack of tenured or ring-fenced positions in institutions
to incentivize the return of those clinician-scientists who have
acquired post-graduate research outside their countries (27).

Poor Representation of LMIC Researchers
Global health forums address issues of insufficient resources,
funding, and capacity in LMICs. However, for over a decade
the Global South (predominantly LMICs) continue to receive
sparse representation on leading global health boards and
executive councils. It is estimated that 85% of the global
health organization headquarters are in the Global North (29).
These organizations have established advocacy pathways and
funding resources to address global health problems in the
Global South which may not be contextually relevant (29). The
Consortium of Universities for Global Health (CUGH) is one
of the world’s largest academic-based organizationss established
in 2007 to support academic institutions in addressing global
health challenges. In 2016, only two out of the 16-member
Board of Directors of CUGH were from the Global South (31).
This inequity steers most of the capacity building and training
for academic programs in global health toward the Global
North while the disease burden exists in the South. Similarly,
commissioners from HICs led 72% of the Global Surgery and
73% of the Global Health Lancet commissions (31). Due to
the massive underrepresentation of LMIC attendees in global
health conferences, the issues facing them are not brought to the
forefront. Barely 4% of academic conferences are held in lowincome countries, representing <40% of delegates from LMICs
(29). This poor representation is due to financial constraints,
visa restrictions, political barriers, and failure to actively seek
and identify expertise from LMICs (29). Even amongst the
low numbers of attendees from LMICs, those that attend have
minimal active speaking opportunities, research presentations,
and support, thus making their voices left unheard (29). When
clinicians and researchers have no opportunities to participate
in decision-making panels, it hampers their research interests
as their efforts seem to add no significant value to impact
clinical guidelines.

Limited Capacity to Do Research or
Generate Evidence
While the challenge of resources and funds can be addressed
through different means (e.g., philanthropy), mentoring local
researchers to pursue careers in clinical research is another
tremendous challenge. These challenges are mainly due to a
scarcity of infrastructure with very few research laboratories,
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FIGURE 1 | Theory of change around increasing data generation and contextual research output in LMICs.

Hierarchal Relation Between HIC and LMIC
Research Collaborators

of global health publications have reported inequalities in
global health research overall, with marginalization and
disempowerment of LMIC authors (35). HICs publish almost
all global health journals with very few editor-in-chiefs from
LMICs and low representation of editors or editorial board
members from LMICs (32). Top 12 health journals have 33%
LMIC representation amongst editors and editorial board
members (31). Amongst 27 specialty global health journals, 68%
of editors and 73% of editors-in-chief came from HICs (36).
Consequently, there is an increased preference for publishing
research conducted by the developed countries of the Global
North (31). This disparity was further aggravated amongst
leading female roles from LMICs, encompassing only 4% of
leading female editors belonging from LMICs amongst the top 12
health journals (31). LMIC female first authors had manuscripts
published in journals with impact factors ∼ 14 points lower
than papers from their HIC counterparts (36). A systematic
analysis of current trends in authorship demographics for global
surgery publications reported 51% of authors affiliated only
with HICs with over two-thirds of first and last authors were
affiliated with at least one HIC institution (35). Elite journals
frequently reject papers from LMICs with the presumption of
it being of questionable data quality, not of interest to their
reader or findings not being generalizable to HICs. Subsequently,
authors are advised to submit their articles to local low-impact
journals resulting in lower reach and hence limited citations.
Unaffordable publication costs of other impactful global health
journals add to this engrained disparity and further restrict
southern data from being published in reputable journals (37).

In research collaborations between HIC and LMICs, when
decisions and conversations partake, the voices and concerns of
these researchers in LMIC (usually taking role of “gatekeepers)”
remain typically absent. As a result, plans made through such
“collaborations” do not align with the academic programs,
timetables and teaching systems of centers in the south. This unidirectional “gatekeeping” attitude to “facilitate” scholars from
the Global North consumes more resources, time, energy, with
little to no emphasis on improvement opportunities (30). An
additional challenge is that funding is directed usually toward
institutions in the Global North and researchers in Global South
being dependent on the funds tend to not speak about these
issues and may continue to suffer in silence. The dependence
on such funds is also a reason for institutions in LMICs to not
support their researchers when they share their concern about
such hierarchy in collaborations (33, 34).

Publication Bias
Publications in reputable global health journals allows
dissemination of identified local challenges and contextual
sustainable solutions and thus can direct future policymaking.
The power imbalances within global surgery academia are
at risk of being transferred to national policy and adversely
affecting resource allocation (35). In an ideal situation, even
if LMIC researchers tackle all the major gaps in resources and
representation to conduct locally relevant research, publication
bias still limits their credibility and voice. Bibliometric studies
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TABLE 1 | A theory of change model to increase data generation and contextual research in low- to middle- income countries.
Impact: Improved evidence generation and contextual research for optimal CHD care
N (%): Increase in available health outcome metric datasets, increase in number of papers on data from LMIC authored by investigators from Global south.
Intermediate Outcome: Improved resources, representation, and publications
N (%):
1. Increase in the number of resources: Amount in $ funding toward health outcome research in LMIC and number of high quality LMIC researchers and other
supporting staff (e.g., statisticians, data scientist etc)
2. Increase diversity in global health advisory, editorial and conference representation
3. Increase in the number of publications and citations from LMICs lead investigators.
Pre-conditions

Interventions

Indicator/Metrics

• Involving key stakeholders (patients, physicians, insurance
companies, pharmaceuticals/device companies, government health
ministries).
• Demonstrating value in investing in data especially health outcome
metrics at a micro (individual- physician or patient or institutionalhospital, academic medical centers) or a macro-level (governmenthealth ministries)
• Creating holistic impact outcomes for healthcare workers and
institutions thus tying in health outcome data and research to
improved human capacity and productivity i.e., a healthy individual
will have less working days lost and less expenditure on a healthy
workforce for company with health insurance benefits.
• Demonstrating benefits of value-based health care to
pharmaceuticals/device industry, insurance companies.
• Incentive for government health authorities to invest in data
generation and research around health outcomes thus helping them
objectively and effectively allocate health budget.
• Educate stakeholders (industry, insurances, government,
philanthropist etc) about better return of their investment through
data and research driven improved quality of care.
• Increased transparency of external grants by ensuring allocation of
external grants alignment with the national health care needs and in
consultation with the community.
• Prevent centralization of resources by funding research in all
geographic areas regardless of economy status

– Number of disease specific health outcome registries or
collaboratives created nationally.
– Number of block chain start-ups managing health outcome
data emerging locally.
– Number of national conferences or meeting around
contextual data generation and health outcome research
including all stakeholders.
– Number of health care providing entities collecting and
providing health outcome data.
– Number of corporate health care entities (device companies,
pharmaceuticals) with dedicated health outcome funding
budgets.

• Preferential health budget support of federal funds to institutions
demonstrating robust research activities, improvement in healthcare
based on contextual data generation and research capacity building.
• National academic institutional collaborations amongst various
schools–health, humanities, business, engineering, information and
technology–to promote a culture of innovation and entrepreneurship
to tackle healthcare challenges using a multi-disciplinary approach.
Technology transfer and opportunity to create health care startups
and revenue generating opportunities.
• Acknowledging institution which has employee appraisal based on
their contextual research productivity. Encourage institutions to value
impact on health outcome vs. journal impact factors or number of
publications.
• Mandate (at a national level) benchmarking of outcomes and quality
improvement sciences. Highlight programs with improved outcomes
as determined by a third-party auditor (i.e., IQIC)
• Encourage local stakeholders within multiple LMICs to collaboratively
propose optimal and cost-effective solutions to prevalent problems
by sharing their experiences and promote the practice of
evidence-based medicine.

– N (%) of clinicians and researchers at government and
private health institutes involved in conducting research
– Number of scalable technologies and startups created yearly
from graduates of such academic institutions.
– $ funding to institution fulfilling the criteria of a “research”
valuing center.

1. Improved Funding
1.1 Value creation around
contextual evidence and
research among local
stakeholders

1.2 Increased local funding

1.3 Contextually relevant
external funding

– Amount (in $) of research funds allocated by health
care philanthropic organizations, government and insurance
companies
– Reports by large funding agencies of N(%) of local
stakeholders involved in grant evaluation.
– Amount of (in $) external funds allocated to the disease areas
causing the highest morbidity and mortality.
– Geographic mapping of percentage of funding by large
funding agencies
– Amount (in $) amount allocated to health care facilities
clearly demonstrating holistic impact outcomes.

2. Improved research culture
2.1 Value creation around
institutions promoting
contextual research and
capacity building

2.2 Increased participation
in international database
and collaboratives.

– Number of health care delivery entities benchmarking their
health outcomes by being on national or international
registries.

(Continued)
Frontiers in Pediatrics | www.frontiersin.org
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TABLE 1 | Continued
Pre-conditions

Interventions

Indicator/Metrics

2.3 Increased transparency
around funded research
outputs and health
outcome data

• Encourage focus on knowledge translation and innovative projects
pertaining to local solutions
• Develop feedback systems to monitor alignment of resource
allocation and outcome improvement. Monitor newly introduced
modified policies to ensure sustainability.

– Number of nationally funded projects leading to contextual
clinical practice guidelines
– Number of nationally funded research projects
demonstrating improvement in health outcomes.

3. Adequate capacity to do conduct research activities
3.1 Improved training via
northern exchange
programs and mentorship

3.2 Training provided by
academic institutions within
LMICs

3.3 Incentives and fair
growth opportunities

• Online and in person certificate training programs and workshops of
conventional research courses to target larger masses. Sponsored
master’s and doctorate degrees, postdoctoral research positions to
LMIC grantees and trainees.
• Teaching translational and implementational science to encourage
innovation and contextually relevant research that may improve
practice and policy
• Assign mentors to these trainees that can give detailed feedback
and offer continued assistance throughout their journey promoting
research career development. Sustained mentorship should be
lauded, supported and programs demonstrating it prioritized in
receiving global health funds.
• Increased expectations and accountability from exchange program
awardees to build research developmental programs at home
institutes and achieve long term scientific independence.
• Institutional level journal clubs and seminars encouraging lower
resourced health care setups to participate, voice and formulate
research agendas.
• Collaborative platforms by federal bodies to address problems and
suggest sustainable solutions through modified interventions.
Modified care practices need to be documented initially at a local
level via publications in local journals with a larger goal of establishing
national database and guidelines to support these claims.
• At a national level, encourage local health care workers with limited
resources and large patient loads to exchange ideas and information
at health conferences as participants, panelists, speakers, and
advocates to bring neglected local health problems to the table.
Promote large scale evidence-based medicine practices by defining
clear outcomes and objectives of such forums.
• Competitive salaries and benefits for health care workers conducting
research in the communities at government and private institutional
levels.
• Providing technological expertise and tools for improved data
acquisition and health information exchange.
• Health research award programs need to acknowledge high quality
research work aimed at reporting large data, quality improvement
initiatives, creating contextual guidelines and demonstrating
improved health outcomes.

– Number (%) of exchange programs awardees from LMICs
every year at HIC global health institutes.
– Number (%) conference presentations and manuscripts led
by LMICs mentees
– Number (%) of research programs developed by LMICs
mentees in their setups

– Number (%) of research related activities conducted every
year at leading academic health institutes.
– Number (%) local specialized journal publications and their
quality of work.
– Number (%) of national health conferences and participants
diversity across the country.

– Number (%) of national awards given to researchers to
recognize their efforts in improving health outcomes.
– % increment in salaries of researchers based on their
contribution toward improving health outcomes nationally.

4. Increase representation in global health journal, conferences, and governance bodies.
4.1 Regional journals to
target relevant audience.

4.2 Diversity amongst
journal editorial boards and
conferences.

4.3 Inclusion amongst
global health bodies

• Encourage separate local or regional branches of global health
journals which may publish more relevant and applicable data from
local researchers.
• Encourage utilization of publication and the importance of quality of
work over journal impact-factor.
• Increase diversity of representation amongst all journals and
conference stakeholders. This may apply to editor-in-chiefs, editors,
first authors of published articles for top global health journals. This
may also extend to speakers and participants at global health
conferences.
• Systematic reporting system to keep track inclusion in global health
advocacy bodies
• Liaisons with researchers active in eliminating disparity
of representation.
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– Number of leading global health journals having subsets of
regional journals.

– A diversity score similar to the Composite Editorial Board
Diversity (CEBD) score reported by [Bhaumik and Jagnoor
(44)] can assess geographic, ethnic, and country incomelevel diversity.
– Yearly audits of number (%) of LMIC representation in
advisory bodies and editorial boards.
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FIGURE 2 | Conventional vs. Holistic health outcomes in CHD; HRQoL, Health related quality of life.

SOLUTIONS–THE WAY FORWARD

Pre-conditions and Interventions of the
Theory of Change

The most essential aspect of improving research in LMIC is
the realization and ownership of the problem around paucity
of local evidence by patients, health care providers, academic
centers and governments in these countries. In 2015 alone, poor
quality health care in LMIC led to ∼ USD six trillion in economic
losses (38). Thus, all stakeholders must understand that valuing
and investing into data/evidence generation is imperative for
their own benefit. Nationally tailored plans increase ownership
of problems and even though they might not be perfect, they
are likely to have a greater impact (19). Moreover, Southern
voices can only demand inclusivity in global health forums if
they strengthen their systems, collaborate, come forward as a
unified representation to add value to global data. Thus, LMICs
must identify the challenges (as described above) and create a
clear theory of change (ToC) to address these challenges at a
micro- (individual patient or physician or institutions delivering
health care) and a macro- (government and health ministries)
level. ToC has been widely used and it is considered to be the
basis of monitoring and (39) theory-based evaluations (40–42).
According to Weiss, a ToC is, “a theory of how and why an
initiative works (43).” A robust ToC includes several components
that makes the model more systematic (39) i.e., preconditions,
interventions, outcome and goal. Preconditions are a necessary
requirement, condition or element that should be present for
achieving the desired outcome while to fulfill these preconditions
it is important to have efficient interventions that helps achieve
the outcomes and impact of interest (39). Such ToCs are complex
and need a very thoughtful approach. We propose a ToC, its preconditions, interventions and metrics (process and outcome) to
measure the effectiveness of the intervention to enhance research
output from LMICs (Figure 1, Table 1).

Frontiers in Pediatrics | www.frontiersin.org

Improved Funding
It is essential that funds are available to generate evidence
and conduct contextually relevant research. Without funds,
any effort toward creating value around evidence generation
and research activities is not sustainable. The value of having
high quality holistic outcome data and contextual research
especially around quality improvement must be recognized
by all stakeholders i.e., patients, health care providers, health
care delivery facilities and institutions, insurance companies,
health care industry and health ministries/government. Holistic
health outcome data (encompassing the patients mental,
physical and social wellbeing) (Figure 2), contextual research
around service delivery (to improve attainment of healthy
state, degree of health recovery and sustainability of healththe three tier of value-based health care outcomes) and
innovation can benefit the health care ecosystem at a micro(individual and institutional stakeholders) and a macro-level
(government and health ministries). If and when this buyin from local stakeholders comes, funds provided by them
will be more readily and sustainably available. This realization
among stakeholders and subsequent value around contextual
evidence generation and research can be created through
several ways:

Value Creation Around Data and Research Among
Local Stakeholders
It is a win-win situation where all the stakeholders can
benefit if they invest in local evidence generation and
contextual research.
Patient/Family Unit as a Stakeholder. Access to data will
give patients the autonomy to select the best value for their care.
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interest of their country’s health needs. External funders will have
to respect the needs of the local communities and must realize
that their “best” intentions may not necessarily be in the “best”
interest of the local communities. One way of assessing these
needs would be to involve the local health care stakeholders in the
grant evaluation and monitoring process. Feedback mechanisms
should also be encouraged to assess long-term progress amongst
funded projects and whether the funding indeed has impacted
disease burden and local challenges. Transparency of the grant
evaluation process needs immediate attention (23) and the
concept of repeatedly funding the “safe” researcher (48, 49) needs
to be abolished. Building local capacity will only happen by
encouraging early career researchers by funding their work even
if they seem to be a “risky investment.” Evaluation of investigators
must move away from just publications to actual impact. The San
Francisco Declaration on Research Assessment (DORA) points
out that using the Journal Impact Factor as a proxy measure
for the value or quality of specific research may be erroneous
and one-dimensional and lead to a biased research assessment
and perpetuates the emphasis on publication in certain high-tier
journals without a more comprehensive assessment of impact.
Another strategy would be to prevent centralization of resource
allocation and promote equitable distribution in all geographic
areas (50).

Patients can save more money as poor quality of care is more
costly and also leads to more mistrust in the health system which
makes them doctor “shop” (38).
Physician and Health Care Delivery Institution. Ability to
measure and share their outcomes can give these stakeholders
an opportunity to increase their marketability of service, referral,
and remuneration from insurance companies, pharmaceutical
companies, and the healthcare industry. For example, in Pakistan,
atherosclerotic cardiovascular disease (ASCVD) is one of the
leading causes of early mortality in young adults with no
subsequent assessment of risk factors within the population.
The first-ever largest longitudinal cohort study in Pakistan,
PAK SEHAT, is being implemented in collaboration with a
specialized heart hospital, Tabba Heart Institute and Getz
Pharma (https://www.dawn.com/news/1659222) to formulate a
comprehensive database on the native Pakistani population to
assess the likelihood of developing ASCVD. This serves as a
great example of local stakeholders contributing towards locally
relevant research in ways that can also be beneficial for them.
Insurance Companies, Industry, and health care
philanthropists. In many LMICs, the majority of the cost
reimbursement is out of pocket payments (45). Limited health
insurance, government subsidies and philanthropists bear the
cost of care for patients who cannot afford treatment (the
overwhelming majority in LMIC) (46). Having access to health
outcome data and quality improvement research may be of
interest to these stakeholders as it gives them an opportunity to
effectively use their funds. Health care startups like block chain
will also find space in such an environment and becomes another
stream of value creation and incentives for people to invest in
local research activities.
Government. Access to health outcome data and local
research can be of value to governments. It helps them achieve
good health indicator-based international ratings, which helps
governments in LMICs procure more funds and aids from bodies
like the International Monetary Fund (IMF) or the World Bank.
It also helps them in effective and objective use of their health
budgets. Increased medical tourism is another incentive for
governments in LMIC to invest in contextual data generation and
research. These incentives can make the stakeholders value data
and research and thus invest in it as they see it as something that
will give them a good return on their investment (ROI).

Improved Research Culture
Waiting to develop a culture of research only once adequate
resources are available, may never fill the research gaps. The
approach should be to foster a culture of innovation that can
encourage research activities within the available resources. A few
successful innovations can subsequently drive more funds. This
can be done through several different ways.

Value Creation Around Institutions Promoting
Contextual Research and Capacity Building
Academic medical centers should be encouraged to engage in
data generation and research and should be incentivized by
giving such centers better budgetary support. Private centers
should allocate funds toward research activity, publication costs
etc. for clinical research mandated by the government. A
government-level oversight will ensure appropriate utilizations
of the funds by these centers. Other institutions (business schools,
health care leader mentorship programs etc.) should educate
their students on the value of data and its objectivity and
create data-centric systems to aid in decision-making. They can
further educate other stakeholders in the society to propagate a
culture of research and data-driven health care. Creating national
level collaborations between engineering, business, social science
and health care institutions will help develop capacity around
innovative fields like data science, artificial intelligence, social
innovation and entrepreneurship.

Increased Local Funding
Demonstrating “ROI” as money saved by improving health
outcomes through local innovations and contextually relevant
management may help in more sustained local investment. A
dialogue with all the stakeholders along these lines will help
direct their focus on short- and long-term benefits of improved
quality of care offered by investing in contextual research and
data generation.

Increased Participation in International Databases
and Collaboratives

Contextually Relevant External Funding
Research funding by external bodies should be allocated based
on translational impact and according to the local ToC (47). This
has to be mandated by governments in LMICs trickling down
to academic and research organizations as this is in the best
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Use of high quality implementation science has been proposed
to understand the contextual factors associated with the scaling
of surgical systems in LMICs (53). Such quality evidence
around implementation may also help HIC adopt such robustly
tested processes in LMICs. These efforts will hone research
career development amongst young researchers and improve
the workforce. Research collaborations between HIC and LMIC
must include capacity building of the LMIC investigators to lead
manuscripts and present at various conferences and forums. The
accountability of these deliverables has to be monitored by both
the collaborating institutions in HIC and LMICs. One initiative
in this regard, focusing on growing and disseminating talent
in medicine is the Women as One Talent Directory (https://
womenasone.org/register/sign-up/) is a robust and sortable
online database of talented women in medicine to facilitate
professional opportunities and to allow for networking.

(IQIC) for CHD surgery and catheterization, a web-based
platform providing benchmark data on clinical outcomes
and resource utilization metrics, is an exemplary template
for the collaborations that need to be developed. IQIC allows
all institutions, lacking a national database or sufficient
resources, to benchmark outcomes and compare their analyses
with other LMICs centers. In addition, it also encourages
collaborative learning through free webinars and supports
local efforts in research activities and manuscript writings.
Such measures will allow routine interaction amongst global
institutions to share practices and care protocols. It will facilitate
conversations between participating hospitals with similar
resource backgrounds, who desire to improve the quality of their
care and optimize cost-effectiveness and share their experiences
through publications (51).

Increased Transparency Around Funded Research
Outputs and Health Outcome Data

Training Provided by Academic Institutions Within
LMICs

Feedback systems with quarterly reports to assess the progress
of research developments can monitor resource allocation and
outcome improvement. Meanwhile, newly introduced evidencebased modified policies will have to be monitored regularly
to ensure that change sought via these frameworks remains
sustainable. Nevertheless, emphasis should be on translation
projects pertaining to local issues rather than replicating work
done in HICs in a controlled, artificial setup that often cannot
be replicated.

At a micro level, large academic institutes should take the
initiative to increase the pool of local researchers. The handful
of institutions in LMICs which are adequately resourced should
champion the cause and hold mandatory institutional level
journal clubs and seminars, which could be linked to units
without these remotely. This would promote partnerships with
lower resourced health care setups to discuss and formulate
contextual research agendas. The performance and subsequent
funding of such institutions when linked to improvement in
health outcomes, will lead to a more concerted and sustained
effort by these institutions to promote a culture of contextually
relevant research.
At a macro level, federal bodies should develop collaborative
platforms to promote translational research and sharing of
resources. These platforms can be utilized to address health
inequities and encourage innovative sustainable solutions at the
local level. There is a need for the establishment of local health
journals where articles addressing community problems and
data deficits can be published and disseminated. It will help
develop modified interventions targeting the local population
at-need and encourage discourse on outcomes of modified
care practices. If care protocols are accurately reported and
accessible to neighborhood local regions, similar setups can adopt
successful strategies, thereby causing a bigger impact. Consistent
documentation of these practices in multiple centers enables
a wider outreach and acceptance. Furthermore, local health
journals should invite small rural health care setups to publish
data on their patients. Encouraging data from multiple small
centers can help form a larger cumulative database in the future
and impactful local guidelines (54). The student workforce at
teaching hospitals can be given opportunities to participate in
data collection to set up these large databases or do mini-research
projects. They can use incentives of developing their resume and
research mentorship from faculty to participate in these studies.
National governance bodies need to establish health
conferences at a national level as an accessible medium for
exchanging ideas and information. Such conferences need to
have clear objectives and defined outcomes (i.e., establishing of

Adequate Capacity to Conduct Research
Activities
Improved Training via Northern Exchange Programs
and Mentorship
Individuals or experts working in the global health arena should
be encouraged to act as mentors to early career researchers or
clinicians in LMICs. The performance of these experts should
be appraised by their affiliated organizations based on the
quality of the mentees produced. The long-term expectation
should be for these mentees to be autonomous researchers who
demonstrate improvement in health outcomes in their respective
countries through their work. Such systematic approach of
collaborative staff training and knowledge sharing can promote
long-term scientific independence (28). A combination of
training opportunities such as fellowships, certificate programs,
master’s and doctorate degrees, postdoctoral positions can be
offered to LMIC researchers, especially by programs seeking
funding within the global health space. A fixed percentage of
grantees and trainees from LMICs should be sponsored to receive
these certificate and degree programs with the expectations of
building research infrastructures at various institutes in their
home countries. While not everyone can be sponsored to
train at reputable institutes, utilizing virtual platforms to hold
essential research courses at low-to-no costs will allow training
in remote areas. Apart from the conventional research courses
i.e., research design, grant writing, statistics, a special focus
should be given in teaching translational and implementation
science so that investigators are primed to be innovative and
help catalyze uptake of evidence into policy and practice (52).
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Diversity Score (CEBDS) (44) evaluated the diversity in top 27
global health journals amongst gender, geographic and income
level regions serving as a great example to quantify actual
diversity. A detailed assessment based on a globally approved
scoring system may help target the gaps in inclusivity amongst
editorial bodies. Furthermore, an assessment of first authors of all
publications and their citations can help reflect upon the diversity
of acceptance from research conducted in different backgrounds.
The data can also be used by institutions in LMIC to advocate
for more equitable partnerships. Thus, more inclusion will allow
addressing problems in acquiring data at a global level. It will help
devise global initiatives to assist in building capacity and funding
projects to collect data from LMIC.

local databases, exchanging ideas, creating research consortiums,
tracking progress in heath outcome metrics, etc.). Such a
focused approach will help reap the maximum benefit of such
gatherings as such conferences are costly and require intense
organizing efforts. Health care workers with limited access
and large patient loads should be given special attention. They
should be encouraged to participate as panelists, speakers, and
advocates. It will encourage local stakeholders to gather data
through mutual collaboration which can result in comprehensive
solutions to prevalent problems and promote the practice of
evidence-based medicine.
Once local partnerships are forged and local centers are driven
toward establishing national healthcare policies through research
and development, partnerships with programs in other LMICs
with shared problems and challenges can be considered.

Inclusion Amongst Global Health Bodies
A goal for the pediatric heart disease researchers should be
to have a unified voice in global forums like the Sustainable
Developmental Goals (SDGs) to ensure the disease remains a
national priority. This makes the case significantly easier with
governments. Moreover, global health advocacy boards and
global health journals should also work to increase representation
from LMICs through ensuring accountability. Devising a
systematic reporting system to keep track of “expected” vs. “real”
inclusion of LMICs in global health will be fruitful. Measures
should include mandatory yearly audits, reporting the percentage
of LMIC representation in advisory bodies and editorial boards.
These yearly audits will give concrete numbers to point to
the reality of inclusivity and depict trends of improvement
overtime. Liaison with groups of researchers active in the space
of addressing the disparity in representation in global health will
help magnify the efforts toward meaningful inclusivity of LMIC
stakeholders in global health (56).

Incentivization and Fair Growth Opportunities
In LMICs where financial benefits lie within extra clinical
hours, competitive salaries and benefits for contextual research
can incentivize most physicians to begin investing their time
toward contextual research. Such an initiative should be
encouraged at both, government, and private institutional
levels. Recognizing efforts and giving due credit through health
research awards and national recognition can further enhance
their interests.

Increase Representation in Global Health
Journal, Conferences, and Governance
Bodies
Regional Journals to Target Relevant Audience
While global health journals may find it impossible to be
completely inclusive of all regions around the globe, regional
subsets of journals may provide more relevant data grouping
and improved readership while being cognizant of diversity
and inclusivity from all ethnic and income-level backgrounds.
This will increase prospects of publication, consolidate ethnic or
regional groups of similar data and appeal to a more relevant
readership. It will also increase the editorial board members in
numbers and provide an incentive toward larger membership
and improved diversity on decision making panels. Moreover, an
important aspect that stakeholders (e.g., academic institutions)
need to consider is the utilization of the publication. Value has
to be placed on the quality of work and its significance toward
achieving the outcomes rather than the impact-factor of the
journal it gets into (37).

CONCLUSION
There are significant global inequities amongst the division of
global health burden of pediatric cardiac disease and allocation
of resources. These barriers are well known in LMIC countries,
but it is essential to enumerate them to set the scene for the
much less known systemic solutions to address them. Along
with inadequate access to high-quality care, competing health
priorities, fragile health systems, and conflicts, there is an
increased lag of evidence generation and research from LMICs.
Lack of basic epidemiologic understanding of the disease burden
in these regions poses a significant knowledge gap as solutions
can only be developed and sustained if the scope of the problem
is accurately defined. Unaligned funding, poor representation
in global health advocacy bodies, limited opportunities to
publish in global health journals, and limited opportunities
to participate and speak at global health conferences hinder
progress. While global health bodies advocate for these problems,
they tend to take control over local health challenges without
focusing on the necessary investment they require. We have
designed the solutions using a ’Theory of Change (ToC)’
approach to understand how and why certain pathways work.
As highlighted in the ToCs, the path begins with national
ownership at the top leading to empowerment of the LMIC

Diversity Amongst Journal Editorial Boards and
Conferences
Global health journals can support reduction of data disparity
by ensuring greater diversity of their editorial boards ranging
from directors to editors to promote a balanced and fair
perspective. Such an effort can provide a larger number of peerreviewers and encourage submission from studies conducted
in more diverse backgrounds, thus providing a better global
health perspective. A commitment for blinded reviews from
high-tier journals would be welcomed to preserve the quality
and integrity of research reviews (55). Composite Editorial Board
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for the next set of workshops we have with the relevant
stakeholders; for example, the first metric is the number of
national disease-specific collaboratives or registries created. In
our workshop, we will start with this as the outcome and then
map the process with the key stakeholders, including physicians,
insurance companies, pharmaceuticals/device companies, and
government health ministries listed in the second column. The
results of these associated process/outcome metrics will need
at least 5 years for a measurable change and are beyond this
paper’s scope.

clinician to publish, especially around clinical outcome data.
The proposed strategies have been designed in the best interest
of all the stakeholders ensuring sustained engagement of the
process. LMICs need to take it upon themselves to improve
the health of their populations with the intent to gradually
decrease dependence on external funds. The realization must
be that an external can only help if “we” put in the effort to
resolve our complex healthcare challenges. All stakeholders in
society from government bodies, health ministries and systems,
to frontline healthcare workers and patients need to be invested
to address the local health problems. Moreover, interventions can
be designed for a more collaborative and effective HIC-LMIC
and LMIC-LMIC partnership directed at increasing resources,
capacity building and representation for long-term productivity.
We believe that given the strength of the ToC model, it can
be very well used by HIC centers too. As a next step, the
authors will conduct workshops with a group of practitioner
clinicians, hospitals, programs, and other relevant stakeholders
to refine the ToC and its associated process/outcome metrics.
The listed fundamental outcome metrics of each of the
strategies in the ToC table will be the desired goal/outcome
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